{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:59:31Z","timestamp":1793073571926,"version":"4.5.0"},"reference-count":43,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Science And Technology Innovation Team Cultivation Project of the First Affiliated Hospital of Nanchang University","award":["YFYKCTDPY202202"],"award-info":[{"award-number":["YFYKCTDPY202202"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recurrence of hypertriglyceridaemia-associated acute pancreatitis (HTG-AP) is common. Uncontrolled HTG after hospital discharge is an important risk factor for recurrence. However, the optimal triglyceride (TG) goal of lipid-lowering therapy for outpatients remains unclear. The efficacy and safety of intensive TG-lowering therapy on reducing recurrence of HTG-AP trial aims to determine whether intensive TG-lowering therapy (with a TG goal of &lt;150 mg\/dL (equal to 1.7 mmol\/L)), compared with usual care (with a TG goal of &lt;500 mg\/dL (equal to 5.65 mmol\/L)), can reduce recurrence in patients after a first episode of HTG-AP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is an investigator-initiated, multicentre, open-label, parallel, superiority, randomised, controlled trial. Adult patients who have been successfully treated and discharged from their index episode of HTG-AP will be screened for eligibility after a 4-week to 3-month run-in period in the outpatient setting, and then patients with the fasting serum TG levels \u2265150\u2009mg\/dL at baseline are eligible. During the study period, a total of 256 study participants will be randomised to receive either intensive TG-lowering therapy or usual care. In the intensive TG-lowering therapy group, the goal of TG levels is lower than 150\u2009mg\/dL, which will be monitored at 1 month, 3 months, 6 months, 12 months and 18 months after randomisation. In the usual care group, the goal of TG levels is lower than 500\u2009mg\/dL according to the current guidelines. Lifestyle suggestions and TG-lowering agents are the main strategies to manage the lipid level. The primary endpoint is the incidence of recurrent episodes of HTG-AP at 18 months after randomisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has been approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (No. 2023101\u20133). Ethics approval of each participating centre is required before initiation of enrolment. The results of this study will be published in peer-reviewed journals and reported at international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2300073483 (Chinese Clinical Trial Registry)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol version<\/jats:title>\n                    <jats:p>V.4.0 (2024).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093011","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:05:29Z","timestamp":1752833129000},"page":"e093011","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of intensive triglyceride-lowering therapy on reducing recurrence of hypertriglyceridemia-associated pancreatitis (REDUCE): protocol for a multicentre, randomised controlled trial"],"prefix":"10.1136","volume":"15","author":[{"given":"Xin","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Tropical Clinical Trials Unit, Liverpool School of Tropical Medicine, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaifang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei General Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-9662","authenticated-orcid":false,"given":"Lihui","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jingdezhen First People\u2019s Hospital, Jingdezhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ganzhou People\u2019s Hospital, Ganzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yichun people\u2019s hospital, Yichun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, JinJiang Hospital of Traditional Chinese Medicine, Jinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong-Hua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Center of Severe Acute Pancreatitis (CSAP), Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-2306","authenticated-orcid":false,"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Centre for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2025121402500134000_15.7.e093011.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505202"},{"key":"2025121402500134000_15.7.e093011.2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.cgh.2019.11.017","article-title":"Worldwide Variations in Demographics, Management, and Outcomes of Acute Pancreatitis","volume":"18","author":"Matta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121402500134000_15.7.e093011.3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pan.2021.02.005","article-title":"Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: A population-based cohort study","volume":"21","author":"Olesen","year":"2021","journal-title":"Pancreatology"},{"key":"2025121402500134000_15.7.e093011.4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00134-022-06745-7","article-title":"Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial","volume":"48","author":"Ke","year":"2022","journal-title":"Intensive Care Med"},{"key":"2025121402500134000_15.7.e093011.5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.hpb.2022.05.1347","article-title":"Predicting persistent organ failure on admission in patients with acute pancreatitis: development and validation of a mobile nomogram","volume":"24","author":"Shi","year":"2022","journal-title":"HPB (Oxford)"},{"key":"2025121402500134000_15.7.e093011.6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10620-023-08172-0","article-title":"Etiological Changes and Prognosis of Hospitalized Patients with Acute Pancreatitis Over a 15-Year Period","volume":"69","author":"Lai","year":"2024","journal-title":"Dig Dis Sci"},{"key":"2025121402500134000_15.7.e093011.7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejim.2024.03.022","article-title":"Recurrence of hypertriglyceridemia-associated acute pancreatitis: A multicenter, prospective cohort study","volume":"125","author":"Ding","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2025121402500134000_15.7.e093011.8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.14309\/ajg.0000000000002081","article-title":"Acute Pancreatitis Recurrences Augment Long-Term Pancreatic Cancer Risk","volume":"118","author":"Munigala","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2025121402500134000_15.7.e093011.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0087-5"},{"key":"2025121402500134000_15.7.e093011.10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41395-018-0087-7","article-title":"Recurrent Acute Pancreatitis Significantly Reduces Quality of Life Even in the Absence of Overt Chronic Pancreatitis","volume":"113","author":"Cot\u00e9","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2025121402500134000_15.7.e093011.11","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13916","article-title":"Mechanisms linking hypertriglyceridemia to acute pancreatitis","volume":"237","author":"Kiss","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"key":"2025121402500134000_15.7.e093011.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403431101"},{"key":"2025121402500134000_15.7.e093011.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.031"},{"key":"2025121402500134000_15.7.e093011.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2008.01933.x"},{"key":"2025121402500134000_15.7.e093011.15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002573","article-title":"Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity","volume":"3","author":"Navina","year":"2011","journal-title":"Sci Transl Med"},{"key":"2025121402500134000_15.7.e093011.16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304058"},{"key":"2025121402500134000_15.7.e093011.17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/j.gastro.2018.10.034","article-title":"Multimodal Transgastric Local Pancreatic Hypothermia Reduces Severity of Acute Pancreatitis in Rats and Increases Survival","volume":"156","author":"de Oliveira","year":"2019","journal-title":"Gastroenterology"},{"key":"2025121402500134000_15.7.e093011.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-021-01488-8","article-title":"The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis","volume":"20","author":"Sanchez","year":"2021","journal-title":"Lipids Health Dis"},{"key":"2025121402500134000_15.7.e093011.19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacl.2022.08.001","article-title":"GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis","volume":"16","author":"Zhang","year":"2022","journal-title":"J Clin Lipidol"},{"key":"2025121402500134000_15.7.e093011.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182160726"},{"key":"2025121402500134000_15.7.e093011.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.02.003"},{"key":"2025121402500134000_15.7.e093011.22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1190934","article-title":"2023 Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025121402500134000_15.7.e093011.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3213"},{"key":"2025121402500134000_15.7.e093011.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"2025121402500134000_15.7.e093011.25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jamainternmed.2016.6875","article-title":"Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis","volume":"176","author":"Pedersen","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025121402500134000_15.7.e093011.26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s10620-018-5226-x","article-title":"Influence of Ambulatory Triglyceride Levels on Risk of Recurrence in Patients with Hypertriglyceridemic Pancreatitis","volume":"64","author":"Wu","year":"2019","journal-title":"Dig Dis Sci"},{"key":"2025121402500134000_15.7.e093011.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025121402500134000_15.7.e093011.28","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000436438.60145.5a"},{"key":"2025121402500134000_15.7.e093011.29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MCG.0000000000000846","article-title":"Elevated Serum Triglycerides in the Prognostic Assessment of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies","volume":"51","author":"Wang","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"2025121402500134000_15.7.e093011.30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320729"},{"key":"2025121402500134000_15.7.e093011.31","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214654","article-title":"Waist Circumference-Years Construct Analysis and the Incidence of Type 2 Diabetes: China Health and Nutrition Survey, 1997-2015","volume":"14","author":"Xi","year":"2022","journal-title":"Nutrients"},{"key":"2025121402500134000_15.7.e093011.32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7570\/jomes.2019.28.1.40","article-title":"2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea","volume":"28","author":"Seo","year":"2019","journal-title":"JOMES"},{"key":"2025121402500134000_15.7.e093011.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-015-1132-0","article-title":"Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial","volume":"17","author":"Schepers","year":"2016","journal-title":"Trials"},{"key":"2025121402500134000_15.7.e093011.34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hbpd.2019.02.004","article-title":"Guidelines for the diagnosis and treatment of chronic pancreatitis in China (2018 edition)","volume":"18","author":"Zou","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2025121402500134000_15.7.e093011.35","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2025121402500134000_15.7.e093011.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0048-1"},{"key":"2025121402500134000_15.7.e093011.37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacl.2022.11.006","article-title":"Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study","volume":"17","author":"Ding","year":"2023","journal-title":"J Clin Lipidol"},{"key":"2025121402500134000_15.7.e093011.38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pan.2020.02.010","article-title":"Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium)","volume":"20","author":"Pothoulakis","year":"2020","journal-title":"Pancreatology"},{"key":"2025121402500134000_15.7.e093011.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.06.005"},{"key":"2025121402500134000_15.7.e093011.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"BMJ"},{"key":"2025121402500134000_15.7.e093011.41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/2230-8210.129106","article-title":"Treat-to-target trials in diabetes","volume":"18","author":"Wangnoo","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"2025121402500134000_15.7.e093011.42","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.294926"},{"key":"2025121402500134000_15.7.e093011.43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjmed.2013.09.018","article-title":"Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia","volume":"127","author":"Christian","year":"2014","journal-title":"Am J Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T10:50:11Z","timestamp":1765709411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2024-093011"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093011","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}